home / stock / imlff / imlff news

IMLFF News and Press, InMed Pharmaceuticals Inc. From 05/14/20

Stock Information
Company Name: InMed Pharmaceuticals Inc.
Stock Symbol: IMLFF
Market: OTC
Menu
IMLFF IMLFF Quote IMLFF Short IMLFF News IMLFF Articles IMLFF Message Board
Get IMLFF Alerts

News, Short Squeeze, Breakout and More Instantly...
IMLFF - InMed Pharmaceuticals Reports Third Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update

VANCOUVER , May 14, 2020 /PRNewswire/ -  InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN; OTCQX: IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of c...
IMLFF - InMed Files PCT Patent Application for Neuroprotection in Glaucoma

InMed Files PCT Patent Application for Neuroprotection in Glaucoma Canada NewsWire VANCOUVER, May 12, 2020 VANCOUVER , May 12, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical-stage pharmaceutical company developing me...

IMLFF - InMed Pharmaceuticals to Report Third Quarter Fiscal 2020 Financial Results and Business Update on May 14, 2020

InMed Pharmaceuticals to Report Third Quarter Fiscal 2020 Financial Results and Business Update on May 14, 2020 Canada NewsWire VANCOUVER, May 8, 2020 VANCOUVER , May 8, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical...

IMLFF - InMed to Present at Canaccord Genuity's 4th Annual Cannabis Conference

InMed to Present at Canaccord Genuity's 4th Annual Cannabis Conference Canada NewsWire VANCOUVER, May 7, 2020 VANCOUVER , May 7, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN; OTCQX: IMLFF), a clinical-stage pharmaceutical company developin...
IMLFF - InMed and Almac Group Developing Improved Cannabinoid Production Methods

VANCOUVER , May 5, 2020 /PRNewswire/ -  InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cann...

IMLFF - InMed Receives CTA Approval for Second Phase 1 Clinical Trial with INM-755

VANCOUVER , April 30, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN; OTCQX: IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cann...

IMLFF - InMed completes initial early-stage INM-755 CBN cream trial

All the subjects participating in InMed Pharmaceuticals' ( OTCQX:IMLFF ) 755-101-HV Phase 1 trial have completed treatment and clinical evaluation. More news on: InMed Pharmaceuticals Inc., Healthcare stocks news, Read more ...

IMLFF - InMed Announces Completion of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects

InMed Announces Completion of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects Canada NewsWire VANCOUVER, April 1, 2020 VANCOUVER , April 1, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage...

IMLFF - InMed Submits Clinical Trial Application to Evaluate INM-755 in Second Phase 1 Trial

VANCOUVER , March 24, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannab...

IMLFF - InMed provides corporate update

InMed Pharmaceuticals ( OTCQX:IMLFF ) provides an update on the impact of COVID-19 on its business operations. More news on: InMed Pharmaceuticals Inc., Healthcare stocks news, Read more ...

Previous 10 Next 10